These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8515425)

  • 1. Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.
    Keenan RM; Weinstock J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Hill DT; Morgan TM; Samanen JM; Peishoff CE
    J Med Chem; 1993 Jun; 36(13):1880-92. PubMed ID: 8515425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.
    Keenan RM; Weinstock J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Hill DT; Morgan TM; Samanen JM; Hempel J
    J Med Chem; 1992 Oct; 35(21):3858-72. PubMed ID: 1433195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.
    Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT
    J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730
    [No Abstract]   [Full Text] [Related]  

  • 4. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
    Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.
    Sircar I; Winters RT; Quin J; Lu GH; Major TC; Panek RL
    J Med Chem; 1993 Jun; 36(12):1735-45. PubMed ID: 8510101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
    Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
    J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for the chemical development of angiotensin II receptor antagonists.
    Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
    Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
    J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
    Brooks DP; DePalma PD; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Nov; 263(2):422-7. PubMed ID: 1432681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
    J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).
    Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H
    J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
    Wahhab A; Smith JR; Ganter RC; Moore DM; Hondrelis J; Matsoukas J; Moore GJ
    Arzneimittelforschung; 1993 Nov; 43(11):1157-68. PubMed ID: 8292058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
    Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
    Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.